Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « C. Prünte »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
C. Prunet < C. Prünte < C. Pulcini  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
001781 (2012) F. Bandello [Italie] ; J. Cunha-Vaz [Portugal] ; N. V. Chong [Royaume-Uni] ; G. E. Lang [Allemagne] ; P. Massin [France] ; P. Mitchell [Australie] ; M. Porta [Italie] ; C. Prünte [Autriche, Suisse] ; R. Schlingemann [Pays-Bas] ; U. Schmidt-Erfurth [Autriche]New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel
001C81 (2010) P. Mitchell [Australie] ; J-F Korobelnik [France] ; P. Lanzetta [Italie] ; F G Holz [Allemagne] ; C. Prünte [Autriche] ; U. Schmidt-Erfurth [Autriche] ; Y. Tano [Japon] ; S. Wolf [Suisse]Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Ophthalmology
2Vascular endothelium growth factor
1Active disease
1Acuity
1Additional treatment
1Adverse events
1Age related macular degeneration
1Alcon
1Antiangiogenic agent
1Appropriate intervals
1Baseline
1Choroidal
1Choroidal neovascularisation
1Choroidal neovascularization
1Clinical practice
1Clinical recommendation
1Clinical trial
1Clinical trial evidence
1Clinical trials
1Coherence
1Consultancy
1Degeneration
1Diabetes mellitus
1Early treatment
1Epithelial
1Evidence level
1Expert opinion
1Fewer injections
1Flexible strategy
1Fluorescein angiography
1Foveal centre
1Guideline
1Haemorrhage
1Immunomodulator
1Inclusion criteria
1Inhibitor
1Interim data
1Intravitreal
1Intravitreal injections
1Intravitreal ranibizumab
1Ischaemic stroke
1Leakage
1Lesion
1Lesion size
1Lucentis
1Macula
1Macular
1Macular degeneration
1Maintenance phase
1Monthly injections
1Monthly monitoring
1Monthly regimen
1Monthly treatment
1Myocardial infarction
1Natural history
1Neovascular
1Neovascular agerelated macular degeneration
1Neovascular macular degeneration
1Neovascularisation
1Neovascularization
1Novartis
1Novartis pharma
1Occult
1Ophthalmol
1Ophthalmol review table
1Optical coherence tomography
1Pharma
1Photodynamic
1Photodynamic therapy
1Pier
1Pier studies
1Pier study
1Polypoidal choroidal vasculopathy
1Randomised
1Ranibizumab
1Ranibizumab phase
1Ranibizumab therapy
1Ranibizumab treatment
1Recommendation
1Regimen
1Retina
1Retinal
1Retinal angiomatous proliferation
1Retinal pigment epithelial
1Retinopathy
1Retinopathy study charts
1Retreatment
1Risk factors
1Sailor cohort
1Sham
1Sham control
1Snellen
1Study arms
1Study group
1Subfoveal
1Subgroup
1Subgroup analysis
1Subretinal
1Surgical approach
1Systematic review

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "C. Prünte" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "C. Prünte" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Prünte
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024